文献速递认知障碍与痴呆脑血管病

无卒中或痴呆中年人群高血压多基因易感性与认知表现

Polygenic Susceptibility to Hypertension and Cognitive Performance in Middle-aged Persons Without Stroke or Dementia.
PubMed 文献 · Neurology · 2023-06-09

在英国生物银行(UKB)中开展嵌套横断面遗传研究,排除痴呆或卒中史者,按732个遗传风险变异计算的收缩压与舒张压多基因风险评分将高血压多基因易感性(PSH)分为低(≤20百分位)、中、高(≥80百分位)三组。48,118名完成认知评估者中,42,011名为欧洲血统;以收缩压相关变异的多变量回归显示,与低PSH相比,中PSH和高PSH者一般认知能力评分分别降低3.9%(β -0.039,SE 0.012)和6.6%(β -0.066,SE 0.014),p<0.001。

要点

  • 在无痴呆或卒中的中年英国社区居民中,较高的高血压多基因易感性与较差的认知表现相关。
  • 以收缩压相关遗传变异分析,中PSH者一般认知能力评分较低PSH者降低3.9%,高PSH者降低6.6%(p<0.001)。
  • 反应时间、数字记忆和流体智力三项测试驱动了PSH与一般认知能力评分的关联(各单项测试p<0.05)。

核心结论

  • 在无痴呆的社区居住中年英国人中,较高的高血压多基因易感性与较差的认知表现相关,提示高血压遗传易感性影响尚未发生痴呆者的脑健康。

研究设计与样本

  • 在英国生物银行(UKB)内开展的嵌套横断面遗传研究。
  • 排除有痴呆或卒中史的参与者,按732个遗传风险变异生成的收缩压和舒张压两个多基因风险评分,将PSH分为低(≤20百分位)、中、高(≥80百分位)三类。
  • 一般认知能力评分取包含5项认知测试结果分析的第一主成分。
  • 主要分析聚焦欧洲血统者,次要分析纳入所有种族/族裔组;UKB共纳入502,422名参与者,其中48,118名(9.6%)完成认知评估,包括42,011名(8.4%)欧洲血统者。

主要发现

  • 使用收缩压相关遗传变异的多变量回归模型显示,与低PSH参与者相比,中PSH和高PSH参与者的一般认知能力评分分别降低3.9%(β -0.039,SE 0.012)和6.6%(β -0.066,SE 0.014)(p<0.001)。
  • 纳入所有种族/族裔组并使用舒张压相关遗传变异的次要分析得到相似结果(所有检验p<0.05)。
  • 分别评估每项认知测试的分析表明,反应时间、数字记忆和流体智力驱动了PSH与一般认知能力评分之间的关联(所有单项测试p<0.05)。

临床怎么用

  • 作者认为,这些结果为进一步研究利用基因组数据早期识别高风险中年人奠定了基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Mounting evidence indicates that hypertension leads to a higher risk of dementia. Hypertension is a highly heritable trait, and a higher polygenic susceptibility to hypertension (PSH) is known to associate with a higher risk of dementia. We tested the hypothesis that a higher PSH leads to worse cognitive performance in middle-aged persons without dementia. Confirming this hypothesis would support follow-up research focused on using hypertension-related genomic information to risk-stratify middle-aged adults before hypertension develops. METHODS: We conducted a nested cross-sectional genetic study within the UK Biobank (UKB). Study participants with a history of dementia or stroke were excluded. We categorized participants as having low (≤20th percentile), intermediate, or high (≥80th percentile) PSH according to results of 2 polygenic risk scores for systolic and diastolic blood pressure (BP) generated with data on 732 genetic risk variants. A general cognitive ability score was calculated as the first component of an analysis that included the results of 5 cognitive tests. Primary analyses focused on Europeans, and secondary analyses included all race/ethnic groups. RESULTS: Of the 502,422 participants enrolled in the UKB, 48,118 (9.6%) completed the cognitive evaluation, including 42,011 (8.4%) of European ancestry. Multivariable regression models using systolic BP-related genetic variants indicated that compared with study participants with a low PSH, those with intermediate and high PSH had reductions of 3.9% (β -0.039, SE 0.012) and 6.6% (β -0.066, SE 0.014), respectively, in their general cognitive ability score (p < 0.001). Secondary analyses including all race/ethnic groups and using diastolic BP-related genetic variants yielded similar results (p < 0.05 for all tests). Analyses evaluating each cognitive test separately indicated that reaction time, numeric memory, and fluid intelligence drove the association between PSH and general cognitive ability score (all individual tests, p < 0.05). DISCUSSION: Among nondemented, community-dwelling, middle-aged Britons, a higher PSH is associated with worse cognitive performance. These findings suggest that genetic predisposition to hypertension influences brain health in persons who have not yet developed dementia. Because information on genetic risk variants for elevated BP is available long before the development of hypertension, these results lay the foundation for further research focused on using genomic data for the early identification of high-risk middle-aged adults.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rivier CA, Szejko N, Renedo D, et al. Polygenic Susceptibility to Hypertension and Cognitive Performance in Middle-aged Persons Without Stroke or Dementia. Neurology. 2023. PMID: 37295956. doi:10.1212/WNL.0000000000207427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。